Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002402
Filing Date
2025-03-06
Accepted
2025-03-06 16:26:20
Documents
85
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nxtc-20241231x10k.htm   iXBRL 10-K 1942089
2 EX-10.32 nxtc-20241231xex10d32.htm EX-10.32 115137
3 EX-19 nxtc-20241231xex19.htm EX-19 118882
4 EX-23.1 nxtc-20241231xex23d1.htm EX-23.1 10528
5 EX-31.1 nxtc-20241231xex31d1.htm EX-31.1 14863
6 EX-31.2 nxtc-20241231xex31d2.htm EX-31.2 14341
7 EX-32.1 nxtc-20241231xex32d1.htm EX-32.1 12136
8 GRAPHIC nxtc-20241231x10k005.jpg GRAPHIC 57114
9 GRAPHIC nxtc-20241231xex10d32001.jpg GRAPHIC 13036
  Complete submission text file 0001558370-25-002402.txt   8122738

Data Files

Seq Description Document Type Size
10 EX-101.SCH nxtc-20241231.xsd EX-101.SCH 47207
11 EX-101.CAL nxtc-20241231_cal.xml EX-101.CAL 61508
12 EX-101.DEF nxtc-20241231_def.xml EX-101.DEF 140094
13 EX-101.LAB nxtc-20241231_lab.xml EX-101.LAB 462727
14 EX-101.PRE nxtc-20241231_pre.xml EX-101.PRE 318991
88 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20241231x10k_htm.xml XML 1234410
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38905 | Film No.: 25715657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)